A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo
Status:
Not yet recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
Proof of concept, double-blind Randomized Controlled Trial with d-Methadone proposed for the
first time for use in the treatment of patients diagnosed with primary, moderate to very
severe RLS. Its glutamatergic mechanism of action might be effective on Restless Legs
Syndrome arousal pattern and sleep disturbance which highly impair the quality of life of
Restless Legs Syndrome's patients.
Patients must take study drug once a day for 10 consecutive days.